Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the efficacy of lenalidomide plus melphalan and prednisone (MPR) compared to placebo plus melphalan and prednisone (MP) in subjects with newly diagnosed multiple myeloma (MM) who are 65 years of age or older.
Critère d'inclusion
- Multiple myeloma